Although the range of biocatalysts available for the synthesis of enantiomerically pure chiral amines continues to expand, few existingm ethods provide access to secondary amines. To address this shortcoming, we have over-expressed the gene for an (R)-imine reductase [(R)-IRED] from Streptomyces sp. GF3587 in Escherichia coli to create ar ecombinantw hole-cell biocatalyst for the asymmetricr eduction of prochiral imines. The (R)-IRED was screened against ap anel of cyclic imines and two iminium ions and was shown to possess high catalytic activity and enantioselectivity.P reparative-scale synthesis of the alkaloid( R)-coniine (90 %y ield;9 9% ee)f rom the imine precursor was performed on ag ram-scale. Ah omology model of the enzymea ctive site, based on the structure of ac losely related (R)-IRED from Streptomyces kanamyceticus,w as constructed and used to identify potentiala mino acids as targets for mutagenesis.
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Chiral amines are key structural motifs widely found in many naturalp roducts as well as pharmaceuticals, agrochemicals, and fine chemicals. [1] Methods for their preparationi no ptically pure form include organo-and transition-metal-catalyzed asymmetrics ynthesis, [2] although approaches based on classical resolution throughc rystallization or kinetic resolution [3] often remaint he method of choice in industry despite the maximum theoretical yield capped at 50 %. [4] An alternative and attractive strategy for chiral amine synthesis is to employ enzymes, in particular biocatalysts the properties of which have been tailored and enhanced by protein engineering and directedevolution. [5] Notable developments in this area include the use of monoamine oxidases (MAO-N), [6] phenylalanine ammonia lyases, [7] and aminotransferases (transaminases, Scheme1). [8] Additionally,a nl-amino-acid dehydrogenase has recently been subjected to protein engineering and shown to catalyze the asymmetric reductivea mination of ketones (amine dehydrogenases, Scheme 1). [9] In an umber of cases, these biocatalysts have been implemented in large-scale manufacturing processes for the production of activep harmaceutical ingredients as well as their key intermediates. [10] With the exception of MAO-N, whichc an be used for the chemoenzymatic deracemization of amines with broad structural features,t he majority of theseb iocatalysts generate only primary amines,w ith no direct access to secondary or tertiary amines.I nc ontrast,t he asymmetric reduction of imines provides an alternative methodf or generatingt hese motifs. Such an approach has been explored by the development of chemocatalytic processes [11] and also the creationo fa rtificial metalloenzymes, [12] which have been successfully used in tandem with biocatalystsi nc ascade reactions. [13] However,t he enzymatic equivalent of this process remains largely unexplored. [14] Recently,a ni mine reductase [(S)-IRED] from Streptomyces sp. GF3546 expressed in Escherichia coli [15] was shown to catalyze the enantioselective reduction of ar ange of different imines, including 2-substitutedc yclic imines, dihydroisoquinolines, b-carbolines, and also iminium ions. [16] This (S)-IRED was found to be exclusively dependento nt he cofactor NADPHa s as ource of hydride.T he identification of enantiocomplementary enzymes that provide access to both enantiomers of target products remains ak ey challenge in biocatalysis, which has been addressed recently by the development of (R)-selective transaminases [17] and an (R)-selective amine oxidase. [18] Herein Scheme1.Reactions of enzymese mployedi nthe synthesis of chirala mines, with iminer eductase (bottom) representing arecentaddition to available biocatalysts.
we report the heterologous expression and characterization of an enantiocomplementary (R)-IRED from Streptomyces sp. GF3587,w hich has been previously described and found to act on 2-methyl-1-pyrroline 1a,g iving some indication of substrate preference. [19] In this communication, the (R)-IRED is shown to possess aw ide substrate scope and has been applied to the synthesis of the alkaloid coniine 4i on ag ram scale. Additionally,t he imine reductased isplayed significantly higher catalytic activity than previously reported IREDs,w ith ap reference for reducing 6-membered ring piperideine substrates,w hich may provide insight into its natural substrate.
To explore the substrate scope of the (R)-IRED, ap anel of cyclic imines was synthesized ands creenedf or activity.W ith the exception of 1a,a ll 2-substituted iminesw ere prepared by ap reviously reportedm ethod [20] involving the addition of an organometallic Grignard reagent to an N-Boc-protected lactam (Boc = tert-butoxycarbonyl), followed by deprotection of the amine, which undergoes spontaneous cyclization to give the free-base cyclic imine. This flexible approach allowed access to cyclic imines of varying ring sizes with ar ange of substituents. The imines were isolated as their hydrochloride salts to enhance their stabilitya sw ell as water solubility.
Since the only previously reported substrate for the (R)-IRED was 1a,w hich gave excellent conversion( > 98 %) and ee (> 98 %), our initial focus was directed towards screening ar ange of 2-substituted pyrrolines.B iotransformations using resting E. coli cells expressing the (R)-IRED were conducted at substrate concentrations of 5mm with added glucose to aid cofactor recycling (see Supporting Information for the conditions used for cultivation of the recombinantstrain and expression of the (R)-IRED). Negativec ontrolsu sing cells harboring the empty plasmid vector were run in parallel to ensure that any observed activity occurred as ar esult of the IRED biocatalysts.
The (R)-IRED was shown to catalyzet he reduction of pyrrolines containing both aliphatic and aromatic substituents at C-2 (Table 1 ). In addition to the reduction of 1a to (R)-2a [from which the designation as (R)-IRED was derived] the phenyland cyclohexyl-substituted pyrrolines 1b and 1e,r espectively, were fully converted after 24 h; however,as ignificant reduction in enantioselectivity was observed with these bulkiers ubstituents. When a para-methoxy substituent was introduced on the benzene ring, conversion fell to 20 %b ut the reaction proceeded with excellent selectivity to give (S)-2c in > 98 % ee. Under the same conditions, the (R)-IRED gave significantly higher conversions than the previously reported (S)-IRED for pyrroline substrates 1a-d.
To further investigate the substrate scope of the (R)-IRED, whole-cellb iotransformations werep erformed with larger 6-and 7-membered-ring cyclic imine scaffolds. Te trahydroazepines 3a and 3c wereb oth convertedw ith excellents electivity.T he (R)-IRED was found to display particularly high activity towards6 -membered rings,y ielding 2-substitutedp iperidines, which are important scaffolds in many biologically significant compounds. [21] The high activity towards this class of compoundi sa pparent if comparing the conversionso fparamethoxyphenyl-substituted homologues 1c, 3c,a nd 5c (conversions = 20, 50, and ! 98 %, respectively). The biocatalytic reductiono falarge panel of piperideines 5a-m was performed to fully gauge the effects of varying substituents (Table 2) .
Excellent conversionw as observed after 24 hw ithp iperideines 5a-l.R educed conversion of 54 %w as observed with [a] Conversion of starting imine measured after 24 h.
[b] Absolute configuration determined by comparison with previously reported biotransformations with MAO-N. [13] [c]Configuration assigned by analogy of compound to selectivity observed with 1c and 5c. Absolute configuration [16] n/a = Not applicable.
ChemCatChem 2015, 7,579 -583 www.chemcatchem.org benzyl-substituted derivative 5m and detectable conversion was also observed with the bulky 1-naphthyl-substituted 5n, suggestive of an enzyme possessing al arge active site. For substrates bearing phenyld erivatives, the introduction of as ubstituent on the ring led to an increase in enantioselectivity.B oth electron-donating and electron-withdrawing groups were readily accepted, with high conversion and ee observed. Interestingly,amoderate decrease in selectivity was observed if moving the positiono ft he methoxy-substituentf rom para to meta and ortho,s ignaling an increasing contribution of ac ompeting binding mode in which the opposite face of the imine is exposed for reduction by the NADPH.T he (R)-IRED readily accepted other heterocyclic motifs including at hiophene ring (5l).
With simple alkyl and alkenyl substituents,t he (R)-IRED showede xcellent enantioselectivity.I na ddition, reduction of a,b-unsaturated imine 5j proceeded exclusively at the carbonnitrogen double bond with no reduction of the alkene observed. Reductiono fn-propyl-substituted piperideine 5i resulted in the formation of the more active (R)-enantiomer of the natural product coniine in > 98 % ee.T odemonstrate the application of the (R)-IRED biocatalyst for preparative-scale synthesis of chiral amines, the reduction of 5j was performed on a1 .0 g (25 mm)s cale, yielding (R)-coniine 6i (90 %y ield, > 98 % ee), which was isolated as its hydrochlorides alt. In addition to simple 2-substituted piperideines, 3,4-dihydroisoquinolines 7 and 7a were also confirmed to be substrates for the enzyme. Significantly,t he corresponding N-methyl iminium derivatives 9 and 9a were also reduced, with chiral amine 10 a produced with comparable selectivity (74 % ee), albeit with reduced conversion, demonstrating the potential application of this biocatalyst for the synthesis of tertiaryc hiral amines.
Biotransformations of severals ubstrates conducted with the isolated enzyme,c oupled with an NADPH cofactor recycling system using glucose dehydrogenase 2f rom Bacillus megaterium, [22] showed no significant change in enantioselectivity if compared to their whole-cell equivalents, with the exception of dihydroisoquinoline 7a for which unusually the selectivity appeared to diminisht og ive (R)-8a in 47 % ee (see Supporting Information). As the whole-cell biocatalyst requires only the addition of glucosef or cofactor recycling and negates the necessity of using large amounts of NADPH or an additional cofactor recycling system, this approachw as used for any preparative biotransformations.
Kineticp arameters were determined for representative substrates (Table 3) . Kinetic constants with the previously reported (S)-IRED from Streptomyces sp. GF3546 have been described with substrates 1a, 3a, 5a, 7, 7a,a nd 9 (i.e., k cat = 0. ,r espectively).
[16] Excluding 7,s ignificantly higher k cat values andl ower Michaelis constants (K m )w ere observed for the (R)-IRED described herein (Table 3 ). The previously reporteds ubstrate 2-methyl-1-pyrroline 1a had an otably lower k cat /K m value (catalytic efficiency) than severalp iperideine substrates tested. In particular, we observed ag reater than sixty-fold increase in k cat /K m for 2-methyl-1-piperideine 5a over pyrroline 1a.T his preference for 6-and 7-membered ring systems is shared with the (S)-IRED and may allude to the natural function of this class of enzyme. The (R)-IRED also displayed greater activity towards simple alkyl-and alkenyl-substituted imines compared with those bearing aromatic moieties.
As election of ketones and oximes were screened for activity with the (R)-IRED, with no conversion detected (see Supporting Information). The absence of activity towards ketones suggests future potential applications of this enzymef or intermolecular reductivea minations, which remains as ignificant challenge in organic synthesis.
We have recently determined the structure of oxidoreductase Q1EQE0 from Streptomyces kanamyceticus, [22] which shares 50 %s equence identityw ith the (R)-IRED,a nd which also catalyzes the (R)-selective reduction of imine substrates such as 2-methyl-1-pyrroline 1a.T he structureo fQ 1EQE0 revealed ad imeric associationi nw hichtwo monomers associate very closely through domain swapping. The active site, containing NADPH, is ac hannelt hat traverses the width of the dimer.T he active site also revealed residues which mayb er esponsible for catalysis, including Asp187, which was proposed to be the catalytic residue for protonation of the imine in IRED-mediated catalysis. [22] The similarity between the two sequences gave us confidence to build am odel of the (R)-IRED (Figure 1a )u sing the Phyre 2 server. [23] In the model,A sp187 in Q1EQE0i sc onservedi nt he (R)-IRED as Asp172 and many of the other residues within the region of the active site also appear to be conservedb etween the two enzymes (Figure 1b) .
The role of Asp172 in the catalytic mechanism was further probedb yg eneration of the Asp172Ala and Asp172Lysp oint mutantsb ys ite-directedm utagenesis. Interestingly,b oth mutants retained catalytic activity although conversions were generally lower,f or example, for 5c the conversion was reduced from 92 %f or the wild-type isolated protein to 40 %a nd 72 % for the Asp172Ala and Asp172Lys mutants, respectively.R emarkably,r eductiono f5a by the mutants showed no change in enantioselectivity whereas for 7a the ee value was increased to 81 %f or the Asp172Ala variant (Table 4) . These initial studies highlight the importance of this residue as ah otspotf or mutagenesistoi mprove conversionsand/or enantioselectivity.
In summary,t he gene for Streptomyces sp. GF3587 (R)-IRED was overexpressed in E. coli to produce ar ecombinantw holecell biocatalyst possessing broad substrate scope,s uitable for Table 3 . Kineticsdata for cyclicimine substrates 1-7. www.chemcatchem.org the preparation of chiral cyclic secondary amines with broad structural features and with two examples of tertiarya mine synthesis also demonstrated. The activity of the (R)-IRED was shown to be orders of magnitude higher than previously reported imine reductases, which is significant forp otentiali ndustrial applications. [14] Although wild-type IREDs appear to possess relatively broad substrate specificity,f urthere ngineering through directed evolution and rational design, using the protein model presented herein,w ill undoubtedly lead to more active biocatalysts. [25] Moreover,t he opportunity to combine IREDs with existing biocatalysts in cascade reactions [26] should result in greater application of thesee nzymes in asymmetric synthesis. [22] with which it shares 50 %s equence identity and 70 %s imilarity.Subunit Ai ss howni ng reen;s ubunit Bi nc oral. NADPHi ss hown bound at the dimer interface in cylinder format, with carbon atoms in grey.b )Detail of active site, illustrating conservation of active residues between Q1EQE0 and (R)-IREDu sing (R)-IRED numbering. All labeled residues are conserved, exceptT rp206 (replacedbyP he in Q1EQE0) and Phe217 (Trp232), bothshowninred, and Met122 (Leu137) and Ala245 (Thr258), not shown, in the active-site regionclose to the NADPH nicotinamide ring. Asp172,w hich, as Asp187inQ 1EQE0w as suggested to be ac atalytic residue, [22] was selected for mutational studies. 
